FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024885328> ?p ?o ?g. }

• W2024885328 endingPage "26" @default.
• W2024885328 startingPage "20" @default.
• W2024885328 abstract "BackgroundBypass graft disease is related to proliferation and migration of vascular smooth muscle cells and to platelet activation with thrombus formation. Nitric oxide inhibits these biological responses; it has never been demonstrated, however, whether this occurs in intact human vascular tissue after endothelial nitric oxide synthase gene transfer.MethodsWe examined whether endothelial nitric oxide synthase overexpression inhibits biological features of bypass graft disease in saphenous vein tissue.ResultsThe nitric oxide donor diethylenetriamineNONOate inhibited proliferation (P < .001) and migration (P < .001) of human saphenous vein vascular smooth muscle cells in response to 20% serum in a concentration-dependent manner. A similar effect on proliferation (P < .05) and migration (P < .05) without any cytotoxicity was observed after adenoviral endothelial nitric oxide synthase transfection. Staining of saphenous vein tissue for placental alkaline phosphatase demonstrated that adenoviral transfection was efficient. Consistent with this observation, endothelial nitric oxide synthase protein expression and nitric oxide release were enhanced in transfected tissue. Further, endothelial nitric oxide synthase overexpression inhibited vascular smooth muscle cell outgrowth from saphenous vein explants over 21 days; 48% ± 12% of explants exhibited outgrowth after treatment with endothelial nitric oxide synthase adenovirus as compared with 69% ± 10% in those infected with control adenovirus and 90% ± 5% in uninfected tissue (P < .05). Similarly, platelet adhesion to human saphenous vein tissue was inhibited by endothelial nitric oxide synthase overexpression; adhesion was reduced in segments infected with endothelial nitric oxide synthase adenovirus (58% ± 6%) as compared with those infected with control adenovirus (107% ± 8%) or uninfected saphenous vein (100%; P < .05).ConclusionsThese data demonstrate that endothelial nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in intact human saphenous vein tissue. Therefore, endothelial nitric oxide synthase transfection represents a promising gene transfer approach to prevent venous bypass graft disease." @default.
• W2024885328 created "2016-06-24" @default.
• W2024885328 creator A5001293774 @default.
• W2024885328 creator A5037096886 @default.
• W2024885328 creator A5045293936 @default.
• W2024885328 creator A5083918379 @default.
• W2024885328 creator A5090355357 @default.
• W2024885328 date "2004-01-01" @default.
• W2024885328 modified "2023-10-17" @default.
• W2024885328 title "Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein" @default.
• W2024885328 cites W1568858788 @default.
• W2024885328 cites W1987287136 @default.
• W2024885328 cites W1988803492 @default.
• W2024885328 cites W1988896841 @default.
• W2024885328 cites W1989692669 @default.
• W2024885328 cites W1990027252 @default.
• W2024885328 cites W1999497040 @default.
• W2024885328 cites W2015628016 @default.
• W2024885328 cites W2059154127 @default.
• W2024885328 cites W2066963386 @default.
• W2024885328 cites W2069957293 @default.
• W2024885328 cites W2073396491 @default.
• W2024885328 cites W2080214188 @default.
• W2024885328 cites W2084691868 @default.
• W2024885328 cites W2085973231 @default.
• W2024885328 cites W2090343238 @default.
• W2024885328 cites W2098264302 @default.
• W2024885328 cites W2099069840 @default.
• W2024885328 cites W2104576349 @default.
• W2024885328 cites W2153458492 @default.
• W2024885328 cites W2154023987 @default.
• W2024885328 cites W2168300710 @default.
• W2024885328 cites W2328870579 @default.
• W2024885328 cites W2331162989 @default.
• W2024885328 cites W2337043297 @default.
• W2024885328 cites W4290310677 @default.
• W2024885328 doi "https://doi.org/10.1016/j.jtcvs.2003.07.021" @default.
• W2024885328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14752408" @default.
• W2024885328 hasPublicationYear "2004" @default.
• W2024885328 type Work @default.
• W2024885328 sameAs 2024885328 @default.
• W2024885328 citedByCount "12" @default.
• W2024885328 countsByYear W20248853282013 @default.
• W2024885328 countsByYear W20248853282021 @default.
• W2024885328 crossrefType "journal-article" @default.
• W2024885328 hasAuthorship W2024885328A5001293774 @default.
• W2024885328 hasAuthorship W2024885328A5037096886 @default.
• W2024885328 hasAuthorship W2024885328A5045293936 @default.
• W2024885328 hasAuthorship W2024885328A5083918379 @default.
• W2024885328 hasAuthorship W2024885328A5090355357 @default.
• W2024885328 hasBestOaLocation W20248853281 @default.
• W2024885328 hasConcept C104317684 @default.
• W2024885328 hasConcept C123012128 @default.
• W2024885328 hasConcept C126322002 @default.
• W2024885328 hasConcept C153911025 @default.
• W2024885328 hasConcept C202751555 @default.
• W2024885328 hasConcept C2776992346 @default.
• W2024885328 hasConcept C2777622882 @default.
• W2024885328 hasConcept C2778326061 @default.
• W2024885328 hasConcept C2779395532 @default.
• W2024885328 hasConcept C2908688039 @default.
• W2024885328 hasConcept C2992686903 @default.
• W2024885328 hasConcept C519581460 @default.
• W2024885328 hasConcept C54009773 @default.
• W2024885328 hasConcept C55493867 @default.
• W2024885328 hasConcept C71924100 @default.
• W2024885328 hasConcept C86803240 @default.
• W2024885328 hasConceptScore W2024885328C104317684 @default.
• W2024885328 hasConceptScore W2024885328C123012128 @default.
• W2024885328 hasConceptScore W2024885328C126322002 @default.
• W2024885328 hasConceptScore W2024885328C153911025 @default.
• W2024885328 hasConceptScore W2024885328C202751555 @default.
• W2024885328 hasConceptScore W2024885328C2776992346 @default.
• W2024885328 hasConceptScore W2024885328C2777622882 @default.
• W2024885328 hasConceptScore W2024885328C2778326061 @default.
• W2024885328 hasConceptScore W2024885328C2779395532 @default.
• W2024885328 hasConceptScore W2024885328C2908688039 @default.
• W2024885328 hasConceptScore W2024885328C2992686903 @default.
• W2024885328 hasConceptScore W2024885328C519581460 @default.
• W2024885328 hasConceptScore W2024885328C54009773 @default.
• W2024885328 hasConceptScore W2024885328C55493867 @default.
• W2024885328 hasConceptScore W2024885328C71924100 @default.
• W2024885328 hasConceptScore W2024885328C86803240 @default.
• W2024885328 hasIssue "1" @default.
• W2024885328 hasLocation W20248853281 @default.
• W2024885328 hasLocation W20248853282 @default.
• W2024885328 hasLocation W20248853283 @default.
• W2024885328 hasOpenAccess W2024885328 @default.
• W2024885328 hasPrimaryLocation W20248853281 @default.
• W2024885328 hasRelatedWork W102080802 @default.
• W2024885328 hasRelatedWork W1196822169 @default.
• W2024885328 hasRelatedWork W1903672112 @default.
• W2024885328 hasRelatedWork W2036533624 @default.
• W2024885328 hasRelatedWork W2061658648 @default.
• W2024885328 hasRelatedWork W2064082378 @default.
• W2024885328 hasRelatedWork W2084476384 @default.
• W2024885328 hasRelatedWork W2091715834 @default.
• W2024885328 hasRelatedWork W2170387219 @default.

• next